These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 2745974)
1. Tumor idiotype vaccines. VI. Synergistic anti-tumor effects with combined "internal image" anti-idiotypes and chemotherapy. Chen JJ; Saeki Y; Shi LF; Köhler H J Immunol; 1989 Aug; 143(3):1053-7. PubMed ID: 2745974 [TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of dendritic cell vaccination and anti-CD20 antibody treatment in the therapy of murine lymphoma. Gadri Z; Kukulansky T; Bar-Or E; Haimovich J; Hollander N J Immunother; 2009 May; 32(4):333-40. PubMed ID: 19342972 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the idiotypic network in tumor immunity. Raychaudhuri S; Saeki Y; Chen JJ; Kohler H J Immunol; 1987 Dec; 139(11):3902-10. PubMed ID: 2824616 [TBL] [Abstract][Full Text] [Related]
4. Tumor-specific idiotype vaccines. I. Generation and characterization of internal image tumor antigen. Raychaudhuri S; Saeki Y; Fuji H; Kohler H J Immunol; 1986 Sep; 137(5):1743-9. PubMed ID: 3018080 [TBL] [Abstract][Full Text] [Related]
5. Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein. Kaminski MS; Kitamura K; Maloney DG; Levy R J Immunol; 1987 Feb; 138(4):1289-96. PubMed ID: 3492546 [TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma. Timmerman JM; Singh G; Hermanson G; Hobart P; Czerwinski DK; Taidi B; Rajapaksa R; Caspar CB; Van Beckhoven A; Levy R Cancer Res; 2002 Oct; 62(20):5845-52. PubMed ID: 12384547 [TBL] [Abstract][Full Text] [Related]
7. Tumor idiotype vaccines. VII. Analysis and correlation of structural, idiotypic, and biologic properties of protective and nonprotective Ab2. Raychaudhuri S; Kang CY; Kaveri SV; Kieber-Emmons T; Köhler H J Immunol; 1990 Jul; 145(2):760-7. PubMed ID: 2164069 [TBL] [Abstract][Full Text] [Related]
8. Idiotype matching: correlation of expression of protective idiotype in sera with survival of tumor mice. Chen JJ; Saeki Y; Köhler H J Immunol; 1990 Jan; 144(2):759-64. PubMed ID: 2295810 [TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapy. Coscia M; Mariani S; Battaglio S; Di Bello C; Fiore F; Foglietta M; Pileri A; Boccadoro M; Massaia M Leukemia; 2004 Jan; 18(1):139-45. PubMed ID: 14574332 [TBL] [Abstract][Full Text] [Related]
10. Idiotype vaccination post-bone marrow transplantation for B-cell lymphoma: initial studies in a murine model. Kwak LW; Campbell M; Levy R Cancer Detect Prev; 1991; 15(4):323-5. PubMed ID: 1794139 [TBL] [Abstract][Full Text] [Related]
11. Tumor-specific idiotype vaccines. II. Analysis of the tumor-related network response induced by the tumor and by internal image antigens (Ab2 beta). Raychaudhuri S; Saeki Y; Chen JJ; Iribe H; Fuji H; Kohler H J Immunol; 1987 Jul; 139(1):271-8. PubMed ID: 2953815 [TBL] [Abstract][Full Text] [Related]
12. Combined therapeutic effect of a monoclonal anti-idiotype tumor vaccine against NeuGc-containing gangliosides with chemotherapy in a breast carcinoma model. Fuentes D; Avellanet J; Garcia A; Iglesias N; Gabri MR; Alonso DF; Vazquez AM; Perez R; Montero E Breast Cancer Res Treat; 2010 Apr; 120(2):379-89. PubMed ID: 19377876 [TBL] [Abstract][Full Text] [Related]
13. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype. Shearer MH; Bright RK; Kennedy RC Cancer Res; 1993 Dec; 53(23):5734-9. PubMed ID: 7694794 [TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of established murine B cell lymphoma. Combination of idiotype immunization and cyclophosphamide. Campbell MJ; Esserman L; Levy R J Immunol; 1988 Nov; 141(9):3227-33. PubMed ID: 3049819 [TBL] [Abstract][Full Text] [Related]
15. Vaccination with membrane-associated idiotype provides greater and more prolonged protection of animals from tumor challenge than the soluble form of idiotype. Ghosh SK; White LM; Ghosh R; Bankert RB J Immunol; 1990 Jul; 145(1):365-70. PubMed ID: 1972719 [TBL] [Abstract][Full Text] [Related]
16. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors. Nitta K; Tanaka T; Takeuchi M Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657 [TBL] [Abstract][Full Text] [Related]
17. Idiotypic intramolecular help. Induction of tumor-specific antibodies by monoclonal anti-idiotypic antibody with the help of Fc-specific T helper clones. Saeki Y; Chen JJ; Shi LF; Kohler H J Immunol; 1989 Apr; 142(8):2629-34. PubMed ID: 2522964 [TBL] [Abstract][Full Text] [Related]
18. Regulation of the BALB/c anti-p-azophenylarsonate antibody response by monoclonal anti-idiotype. II. Idiotope expression in serum and its regulation. Brown AR; Sealy RE J Immunol; 1986 Jul; 137(2):610-7. PubMed ID: 3522733 [TBL] [Abstract][Full Text] [Related]
19. Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy. Massaia M; Borrione P; Battaglio S; Mariani S; Beggiato E; Napoli P; Voena C; Bianchi A; Coscia M; Besostri B; Peola S; Stiefel T; Even J; Novero D; Boccadoro M; Pileri A Blood; 1999 Jul; 94(2):673-83. PubMed ID: 10397734 [TBL] [Abstract][Full Text] [Related]
20. Tumor-specific idiotype vaccines. III. Induction of T helper cells by anti-idiotype and tumor cells. Raychaudhuri S; Saeki Y; Chen JJ; Kohler H J Immunol; 1987 Sep; 139(6):2096-102. PubMed ID: 2442262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]